The new BTX 1702 program is being expedited based on the recent Phase 2 acne study data andmechanistic data recently generated by Botanix that showed synthetic cannabidiol exerts powerfulanti-inflammatory and antimicrobial actions in skin – two key activities that are critical to successfullytreating rosacea
The new BTX 1702 program is being expedited based on the recent...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
37.8¢ |
Change
0.053(16.2%) |
Mkt cap ! $660.6M | |||
| Open | High | Low | Value | Volume |
| 33.0¢ | 38.0¢ | 33.0¢ | $6.441M | 17.88M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 15 | 569465 | 37.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 757437 | 25 |
View Market Depth
| Last trade - 15.44pm 12/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |